Carole Dufouil is an expert in Neurology at Centre Hospitalier Universitaire de Bordeaux (France). As of October 2026, ScienceLeadR ranks Carole Dufouil in the top 1% of experts worldwide for Cognitive Dysfunction, Cognition Disorders and Alzheimer Disease. Carole Dufouil has authored 355 publications, the most recent in 2026, and is an investigator in 7 clinical trials. SLR score: 1,132 (community average: 125). How the SLR is computed.

LeadR Profile

1 132 ScienceLeadR Reputation 1132
Network Map

Neurology

Subspecialties: Public Health - Genetics - Psychiatry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1995 - 2026

Source: PubMed

INSERM

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 355

Citations

Citations: 39 738 1st author: 35 Last author: 45 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Public brain health: a framework for action to promote and safeguard brain health.
PMID 42897621 — brain
BMC Glob Public Health20260
Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.
PMID 42441390 — alzheimer disease, positron-emission tomography, diagnosis, amyloid
JAMA Top journal20267
APOE-stratified genome-wide association analyses provide insights into the genetic etiology of Alzheimers's disease.
PMID 42736378 — genes, dementia, genome, therapeutics, apolipoproteins e
Nat Genet20260
Heterogeneous trajectories of executive function in clinical Alzheimer's disease: Results from the 3C study.
PMID 42318440 — life style, alzheimer disease, executive function, cognitive dysfunction, prognosis, prospective studies
Alzheimers Dement (Amst)20260
Methodological approaches to account for assay changes in longitudinal biomarker analysis: insights from Alzheimer's blood biomarkers in the MEMENTO cohort.
PMID 42265779 — research design, blood, alzheimer disease, biomarkers
Alzheimers Res Ther20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Director: 3

By phase:

N/A 5
Phase 3 2

By status:

Completed 7

By type:

Interventional 6
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 1
multicentricup10 5

Main Topics

Cohort/Consortium Investigators 4

LeadR Networks

Main global connection map